Purple Biotech Ltd.
Symbol: PPBT
NASDAQ
0.67
USDTržní cena dnes
-0.6807
Poměr P/E
-0.0254
Poměr PEG
17.38M
MRK Cap
- 0.00%
Výnos DIV
Purple Biotech Ltd. (PPBT) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 73.01 | 15.4 | 32.1 | 47.2 | |||||||||||
balance-sheet.row.short-term-investments | 4.34 | 0.9 | 17.1 | 36.3 | |||||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-current-assets | 3.29 | 0.4 | 1.1 | 1.3 | |||||||||||
balance-sheet.row.total-current-assets | 76.3 | 15.8 | 33.3 | 48.5 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 2.18 | 0.5 | 0.7 | 0.9 | |||||||||||
balance-sheet.row.goodwill | 112.06 | 28 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 0.11 | 0 | 20.7 | 20.5 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 112.18 | 28 | 20.7 | 20.5 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0.2 | |||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0.2 | |||||||||||
balance-sheet.row.total-non-current-assets | 114.36 | 28.5 | 21.4 | 21.7 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 190.66 | 44.3 | 54.6 | 70.2 | |||||||||||
balance-sheet.row.account-payables | 10.15 | 3.5 | 2.1 | 1.5 | |||||||||||
balance-sheet.row.short-term-debt | 0.74 | 0.2 | 0.2 | 0.2 | |||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.long-term-debt-total | 0.87 | 0.2 | 0.3 | 0.6 | |||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 13.01 | 3.5 | 4.7 | 2.6 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 3.95 | 2.8 | 0.5 | 0.8 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 1.42 | 0.2 | 0.5 | 0.7 | |||||||||||
balance-sheet.row.total-liab | 27.85 | 10 | 7.5 | 5.1 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.retained-earnings | -520.12 | -137.5 | -117.6 | -95.9 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 69.19 | 38.5 | 10.1 | 8.8 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 613.23 | 133.2 | 154.4 | 152 | |||||||||||
balance-sheet.row.total-stockholders-equity | 162.29 | 34.2 | 46.9 | 64.8 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 190.66 | 44.3 | 54.6 | 70.2 | |||||||||||
balance-sheet.row.minority-interest | 0.51 | 0.1 | 0.2 | 0.3 | |||||||||||
balance-sheet.row.total-equity | 162.81 | 34.3 | 47.1 | 65.1 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 190.66 | - | - | - | |||||||||||
Total Investments | 4.34 | 0.9 | 17.1 | 36.5 | |||||||||||
balance-sheet.row.total-debt | 1.61 | 0.4 | 0.5 | 0.7 | |||||||||||
balance-sheet.row.net-debt | -67.07 | -14.1 | -14.5 | -10.1 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -19.95 | -19.9 | -21.8 | -17.8 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0.2 | 0.2 | 0.2 | 0.2 | |||||||||||
cash-flows.row.deferred-income-tax | 0.64 | -0.8 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 1.88 | 1.9 | 2.4 | 2.1 | |||||||||||
cash-flows.row.change-in-working-capital | 0.27 | 0.3 | 3.3 | 0.6 | |||||||||||
cash-flows.row.account-receivables | 0 | 0.2 | 0.3 | -0.3 | |||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0.6 | |||||||||||
cash-flows.row.account-payables | 1.33 | 1.3 | 0.8 | 0.3 | |||||||||||
cash-flows.row.other-working-capital | -1.06 | -1.2 | 2.1 | 0 | |||||||||||
cash-flows.row.other-non-cash-items | -2.9 | -0.9 | -0.8 | -0.1 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -19.86 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.2 | -0.1 | |||||||||||
cash-flows.row.acquisitions-net | -3.55 | -3.5 | 0 | 0 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 16.68 | 16.7 | 19.8 | 13.2 | |||||||||||
cash-flows.row.other-investing-activites | 0.67 | 0 | 0.3 | 0.4 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 13.8 | 13.1 | 19.9 | 13.4 | |||||||||||
cash-flows.row.debt-repayment | -0.17 | -0.2 | -0.2 | -0.2 | |||||||||||
cash-flows.row.common-stock-issued | 5.86 | 5.7 | 1.5 | 0.6 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-financing-activites | -0.93 | -0.9 | -0.2 | 1.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 5.46 | 5.5 | 1.1 | 1.5 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.05 | 0.1 | -0.2 | 0 | |||||||||||
cash-flows.row.net-change-in-cash | -0.54 | -0.5 | 4.1 | -0.4 | |||||||||||
cash-flows.row.cash-at-end-of-period | 68.68 | 14.5 | 15 | 10.9 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 69.22 | 15 | 10.9 | 11.2 | |||||||||||
cash-flows.row.operating-cash-flow | -19.86 | -19.2 | -16.7 | -15.1 | |||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -0.2 | -0.1 | |||||||||||
cash-flows.row.free-cash-flow | -19.86 | -19.2 | -17 | -15.2 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | -0.9 | -0.3 | |||||||||||
income-statement-row.row.cost-of-revenue | 0.2 | 0.2 | 0.2 | 0.2 | |||||||||||
income-statement-row.row.gross-profit | -0.2 | -0.2 | -1.1 | -0.6 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 17.03 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.operating-expenses | 22.22 | 22.1 | 22.6 | 17.9 | |||||||||||
income-statement-row.row.cost-and-expenses | 22.27 | 22.3 | 22.6 | 17.9 | |||||||||||
income-statement-row.row.interest-income | 0.47 | 0.5 | 1 | 0.3 | |||||||||||
income-statement-row.row.interest-expense | 2.19 | 2.2 | 0.1 | 0.2 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | -7.98 | 2.3 | 0.8 | 0.1 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.total-operating-expenses | -7.98 | 2.3 | 0.8 | 0.1 | |||||||||||
income-statement-row.row.interest-expense | 2.19 | 2.2 | 0.1 | 0.2 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0.47 | 0.2 | 1.2 | 0.6 | |||||||||||
income-statement-row.row.ebitda-caps | -20.96 | - | - | - | |||||||||||
income-statement-row.row.operating-income | -12 | -22.3 | -22.6 | -17.9 | |||||||||||
income-statement-row.row.income-before-tax | -19.98 | -20 | -21.8 | -17.8 | |||||||||||
income-statement-row.row.income-tax-expense | -9.54 | -0.1 | -0.9 | 0.6 | |||||||||||
income-statement-row.row.net-income | -19.88 | -19.9 | -20.8 | -18.5 |
Často kladené otázky
Co je Purple Biotech Ltd. (PPBT) celková aktiva?
Purple Biotech Ltd. (PPBT) celková aktiva jsou 44302000.000.
Jaký je roční obrat podniku?
Roční příjmy jsou N/A.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.000.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je -0.807.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je 0.000.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou 0.000.
Co je Purple Biotech Ltd. (PPBT) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je -19880000.000.
Jaký je celkový dluh podniku?
Celkový dluh je 351000.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 22072000.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 14489000.000.